REGN
#238
Regeneron Pharmaceuticals, Inc. - Common Stock
663.0 9 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.22%
Monthly Change
+8.11%
6 month change
-12.16%
Year Change
+15.81%
Previous Close
664.5 2
Open
663.2 3
Low
663.0 9
High
663.2 3
Volume
350
Financials
- Market Capitalization 69.52 B
- Employee 15 K
- Founded 1988
- CEO Leonard Schleifer
- Website www.regeneron.com
- Headquarter New York, United States
- FIGI BBG000C734W3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
18.86
Price to sales ratio
5.59
Dividends per share
0.94
Dividend yield %
0.46
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 125 |  VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 480.25 USD | -1.06% | -9.39% | +7.94% | +1.53% | 121.89 B USD | ||
| 295 |  ARGX argenx SE - American Depositary Shares | 876.25 USD | -0.16% | -5.71% | -1.84% | +54.53% | 54.23 B USD | ||
| 378 |  RVMD Revolution Medicines, Inc. - Common Stock | 183.95 USD | -1.57% | -3.13% | +18.68% | +232.04% | 39.11 B USD | ||
| 386 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 288.06 USD | -3.58% | -8.97% | +1.82% | -9.10% | 38.46 B USD |
Frequently asked questions about Regeneron Pharmaceuticals, Inc. - Common Stock
What is the Regeneron Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) is 663.09. Over the past 24 hours, the stock has changed by -0.22%. Follow the REGN chart for real-time price dynamics.
What is the stock ticker of Regeneron Pharmaceuticals, Inc. - Common Stock?
Regeneron Pharmaceuticals, Inc. - Common Stock trades under the ticker REGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Regeneron Pharmaceuticals, Inc. - Common Stock stock going up?
REGN has changed by -0.01% over the last week, +8.11% over the last month, and +15.81% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Regeneron Pharmaceuticals, Inc. - Common Stock release financial reports?
Yes. You can track Regeneron Pharmaceuticals, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Regeneron Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Regeneron Pharmaceuticals, Inc. - Common Stock reported net income of 727.2 M for the last quarter. The previous quarter showed 844.6 M, which means net income changed by -13.90%.
How many employees does Regeneron Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Regeneron Pharmaceuticals, Inc. - Common Stock has 15.41 K employees. Workforce size can provide additional context about the company's scale and operations.
What is Regeneron Pharmaceuticals, Inc. - Common Stock EBITDA?
Regeneron Pharmaceuticals, Inc. - Common Stock EBITDA is 766.1 M, and its EBITDA margin is 21.25%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Regeneron Pharmaceuticals, Inc. - Common Stock stock?
You can buy Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Regeneron Pharmaceuticals, Inc. - Common Stock stock?
Investing in Regeneron Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the REGN chart and related analysis on metatrader.com as part of your research.